EyeTech One, LLC – 712438 – 07/09/2025
Unapproved New Drugs/Misbranded
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 15 July 2025, approved sebetralstat (Ekterly) for the treatment of hereditary angioedema (HAE) attacks in adults and adolescents aged 12 years and older.